New CAR T approach minimises resistance, helps avoid relapse in non-Hodgkin’s B-cell lymphoma
Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led…
Browsing: Lymphoma
AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial
A combination of copanlisib and rituximab led to a 48 percent reduction in the risk…
Excellent outcomes reported for first targeted therapy for paediatric Hodgkin lymphoma
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to…
Unmarried people given less intensive treatment for mantle cell lymphoma
Mantle cell lymphoma is a malignant disease in which intensive treatment can prolong life. In…
The Enemy Within: Understanding the Mechanisms of R-CHOP Resistance in B-Cell Lymphoma-Replica
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer of lymphocytes, and a large proportion…
The enemy within: Understanding the mechanisms of r-chop resistance in b-cell lymphoma
White blood cells or lymphocytes are the soldiers of our immune system that patrol the…
Improving immunotherapies for blood cancers: real-time exploration in the tumour
Monoclonal antibodies are part of the therapeutic arsenal for eliminating cancer cells. Some make use…
Antihypertensives can decrease bleomycin-induced lung injury
Bleomycin is a drug used to treat certain cancers, such as Hodgkin lymphoma and germ…
CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine (USA) initiated clinical…
Blood-clotting protein: key role in CNS b-cell lymphoma
In people with central nervous system () lymphoma, cancerous B cells accumulate to form tumours…